OraSure Technologies Revenue 2006-2019 | OSUR

OraSure Technologies revenue from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
OraSure Technologies Annual Revenue
(Millions of US $)
2018 $182
2017 $167
2016 $128
2015 $120
2014 $106
2013 $99
2012 $88
2011 $82
2010 $75
2009 $77
2008 $71
2007 $83
2006 $68
2005 $69
OraSure Technologies Quarterly Revenue
(Millions of US $)
Q1 2019 $30
Q4 2018 $50
Q3 2018 $46
Q2 2018 $44
Q1 2018 $42
Q4 2017 $52
Q3 2017 $42
Q2 2017 $40
Q1 2017 $33
Q4 2016 $35
Q3 2016 $32
Q2 2016 $31
Q1 2016 $29
Q4 2015 $32
Q3 2015 $30
Q2 2015 $30
Q1 2015 $27
Q4 2014 $29
Q3 2014 $28
Q2 2014 $26
Q1 2014 $24
Q4 2013 $29
Q3 2013 $25
Q2 2013 $24
Q1 2013 $21
Q4 2012 $22
Q3 2012 $22
Q2 2012 $23
Q1 2012 $21
Q4 2011 $24
Q3 2011 $22
Q2 2011 $19
Q1 2011 $17
Q4 2010 $19
Q3 2010 $19
Q2 2010 $19
Q1 2010 $18
Q4 2009 $21
Q3 2009 $22
Q2 2009 $17
Q1 2009 $17
Q4 2008 $17
Q3 2008 $17
Q2 2008 $19
Q1 2008 $18
Q4 2007 $20
Q3 2007 $21
Q2 2007 $21
Q1 2007 $20
Q4 2006 $18
Q3 2006 $18
Q2 2006 $18
Q1 2006 $15
Q4 2005 $18
Q3 2005 $18
Q2 2005 $17
Q1 2005 $16
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.529B $0.182B
OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $134.025B 26.02
Medtronic (MDT) Ireland $117.659B 17.20
Stryker (SYK) United States $68.704B 24.52
Boston Scientific (BSX) United States $51.899B 24.88
Baxter (BAX) United States $38.763B 24.43
Zimmer Biomet Holdings (ZBH) United States $23.843B 15.32
Smith & Nephew SNATS (SNN) United Kingdom $18.247B 0.00
ResMed (RMD) United States $16.172B 30.90
Canopy Growth (CGC) Canada $15.352B 0.00
Bio-Rad Laboratories (BIO) United States $8.842B 46.88
Aurora Cannabis (ACB) Canada $8.802B 86.80
Perrigo (PRGO) Ireland $6.755B 11.42
Hill-Rom Holdings (HRC) United States $6.504B 19.72
Insulet (PODD) United States $6.200B 451.74
GW Pharmaceuticals (GWPH) United Kingdom $5.280B 0.00
Haemonetics (HAE) United States $5.104B 41.87
ICU Medical (ICUI) United States $4.630B 27.62
Hutchison China MediTech (HCM) China $3.565B 0.00
NuVasive (NUVA) United States $3.164B 25.84
Neogen (NEOG) United States $3.071B 49.94
Agios Pharmaceuticals (AGIO) United States $2.941B 0.00
Quidel (QDEL) United States $2.233B 23.17
National Vision Holdings (EYE) United States $2.120B 45.18
Aphria (APHA) $1.712B 0.00
Cardiovascular Systems (CSII) United States $1.377B 790.80
Phibro Animal Health (PAHC) United States $1.168B 17.50
AtriCure (ATRC) United States $1.136B 0.00
VAREX IMAGING (VREX) United States $1.083B 22.98
Lantheus Holdings (LNTH) United States $0.941B 25.00
NanoString Technologies (NSTG) United States $0.941B 0.00
Omeros (OMER) United States $0.914B 0.00
MacroGenics (MGNX) United States $0.913B 0.00
PetIQ (PETQ) United States $0.806B 19.58
Cerus (CERS) United States $0.754B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.753B 21.11
TG Therapeutics (TGTX) United States $0.609B 0.00
LeMaitre Vascular (LMAT) United States $0.541B 26.20
Surmodics (SRDX) United States $0.527B 76.59
Quanterix (QTRX) United States $0.498B 0.00
Meridian Bioscience (VIVO) United States $0.462B 14.13
Evolus (EOLS) United States $0.440B 0.00
BioLife Solutions (BLFS) United States $0.343B 107.18
Utah Medical Products (UTMD) United States $0.311B 21.52
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.310B 0.00
Vapotherm (VAPO) United States $0.282B 0.00
Rockwell Medical (RMTI) United States $0.267B 0.00
Zynex (ZYXI) United States $0.240B 24.80
Owens & Minor (OMI) United States $0.226B 4.79
Cytosorbents (CTSO) United States $0.223B 0.00
Bovie Medical (APYX) United States $0.204B 0.00
Chimerix (CMRX) United States $0.179B 0.00
Chembio Diagnostics (CEMI) United States $0.134B 0.00
Fonar (FONR) United States $0.134B 7.05
Surface Oncology (SURF) United States $0.111B 0.00
Female Health (VERU) United States $0.103B 0.00
United-Guardian (UG) United States $0.094B 20.70
Neurotrope (NTRP) United States $0.091B 0.00
Insys Therapeutics (INSY) United States $0.079B 0.00
Trinity Biotech (TRIB) Ireland $0.058B 20.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.045B 0.00
Senestech (SNES) United States $0.042B 0.00
GUARDION HEALTH (GHSI) United States $0.032B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.029B 0.00
BRAINSWAY LTD (BWAY) Israel $0.027B 0.00
Valeritas Holdings (VLRX) United States $0.025B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Akers Biosciences Inc (AKER) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.006B 4.60